Cascade-Responsive 2-DG Nanocapsules Encapsulate aV-siCPT1C Conjugates to Inhibit Glioblastoma through Multiple Inhibition of Energy Metabolism.

Aerobic glycolysis is the primary energy supply mode for glioblastoma (GBM) cells to maintain growth and proliferation. However, due to the metabolic reprogramming of tumor cells, GBM can still produce energy through fatty acid oxidation (FAO) and amino acid metabolism after blocking this metabolic pathway. In addition, GBM can provide a steady stream of nutrients through high-density neovascularization, which puts the block energy metabolism therapy for glioma in the situation of "internal and external problems". Herein, based on the abundant reactive oxygen species (ROS) and glutathione (GSH) in the tumor microenvironment and cytoplasm, we successfully designed and developed a cascade-responsive 2-DG nanocapsule delivery system. This nanocapsule contains a conjugate of anti-VEGFR2 monoclonal antibody (aV) and CPT1C siRNA (siCPT1C) linked by a disulfide cross-linker (aV-siCPT1C). The surface of this nanocapsule (2-DG/aV-siCPT1C NC) is loaded with the glycolysis inhibitor 2-DG, and it utilizes GLUT1, which is highly expressed on the blood-brain barrier (BBB) and GBM cells, to effectively penetrate the BBB and target GBM. The nanocapsule realizes multidrug codelivery, jointly blocks glycolysis and FAO of GBM, and reduces angiogenesis. Meanwhile, it also solves the problems of low delivery efficiency of mAb in the central nervous system (CNS) and easy degradation of siRNA. In general, this drug joint delivery strategy could open up a new avenue for the treatment of GBM.

[1]  L. Ellis,et al.  Metformin Bicarbonate-Mediated Efficient RNAi for Precise Targeting of TP53 Deficiency in Colon and Rectal Cancers. , 2022, Nano today.

[2]  Q. Cheng,et al.  Glioma targeted therapy: insight into future of molecular approaches , 2022, Molecular cancer.

[3]  B. Shi,et al.  Cation‐Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy , 2021, Advanced materials.

[4]  Xin-guo Jiang,et al.  Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release , 2021, Advanced science.

[5]  Junbo Zhou,et al.  BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas , 2021, Cancer biology & medicine.

[6]  Kevin C. Johnson,et al.  Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response , 2020, Nature Genetics.

[7]  Alexander E. Lopez,et al.  GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms , 2021, Nature Communications.

[8]  L. Thompson,et al.  The KDR (VEGFR-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas , 2020, Cancer Genomics & Proteomics.

[9]  H. Weiss,et al.  Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer , 2020, Cell Death & Disease.

[10]  F. Gonzalez,et al.  A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis , 2020, Theranostics.

[11]  B. Shi,et al.  Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment , 2020, Advanced materials.

[12]  A. Jaśkiewicz,et al.  2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents , 2019, International journal of molecular sciences.

[13]  P. Mischel,et al.  Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets , 2019, Nature Reviews Cancer.

[14]  X. Dai,et al.  Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells , 2019, BMC Cancer.

[15]  H. Noushmehr,et al.  Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas. , 2019, Neuro-oncology.

[16]  K. Wellen,et al.  Histone lactylation links metabolism and gene regulation , 2019, Nature.

[17]  B. Ren,et al.  Metabolic regulation of gene expression by histone lactylation , 2019, Nature.

[18]  H. Nagasaki,et al.  Identification by nano-LC-MS/MS of NT5DC2 as a protein binding to tyrosine hydroxylase: Down-regulation of NT5DC2 by siRNA increases catecholamine synthesis in PC12D cells. , 2019, Biochemical and biophysical research communications.

[19]  Zhen Gu,et al.  Bioresponsive Protein Complex of aPD1 and aCD47 Antibodies for Enhanced Immunotherapy. , 2019, Nano letters.

[20]  T. Fukami,et al.  Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver–Derived Cells by Attenuating Splicing , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[21]  G. Smagghe,et al.  The South American Fruit Fly: An Important Pest Insect With RNAi-Sensitive Larval Stages , 2019, Front. Physiol..

[22]  Xiaosheng Wang,et al.  Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment , 2019, EBioMedicine.

[23]  Wei Chen,et al.  A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System , 2019, Advanced materials.

[24]  Lei Han,et al.  Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy , 2019, Advanced materials.

[25]  Yihai Cao,et al.  Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance. , 2018, Cell metabolism.

[26]  Ruibin Li,et al.  The protective role of autophagy in nephrotoxicity induced by bismuth nanoparticles through AMPK/mTOR pathway , 2018, Nanotoxicology.

[27]  N. Casals,et al.  CPT1C promotes human mesenchymal stem cells survival under glucose deprivation through the modulation of autophagy , 2018, Scientific Reports.

[28]  Hyung-Seok Kim,et al.  Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality , 2018, The Journal of experimental medicine.

[29]  Shiva Kant,et al.  The interplay between metabolic remodeling and immune regulation in glioblastoma , 2017, Neuro-oncology.

[30]  F. Quintana,et al.  Role of AHR and HIF-1α in Glioblastoma Metabolism , 2017, Trends in Endocrinology & Metabolism.

[31]  Ping Liang,et al.  Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells , 2016, Oncotarget.

[32]  Huile Gao.  Perspectives on Dual Targeting Delivery Systems for Brain Tumors , 2016, Journal of Neuroimmune Pharmacology.

[33]  S. Beloribi-Djefaflia,et al.  Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.

[34]  Peng Zhang,et al.  Expressions of glia maturation factor-β by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma , 2015, Oncotarget.

[35]  Peter Carmeliet,et al.  Metabolism of stromal and immune cells in health and disease , 2014, Nature.

[36]  F. Du,et al.  Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. , 2014, Biomaterials.

[37]  Mark E. Davis,et al.  Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor , 2013, Proceedings of the National Academy of Sciences.

[38]  R. Milo,et al.  Glycolytic strategy as a tradeoff between energy yield and protein cost , 2013, Proceedings of the National Academy of Sciences.

[39]  Michael R. Green,et al.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. , 2012, Cancer cell.

[40]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[41]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[42]  Yu Zhang,et al.  Preparation, Characterization of 2-Deoxy-D-Glucose Functionalized Dimercaptosuccinic Acid-Coated Maghemite Nanoparticles for Targeting Tumor Cells , 2011, Pharmaceutical Research.

[43]  B. Faubert,et al.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.

[44]  T. Merchant,et al.  Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. , 2010, International journal of radiation oncology, biology, physics.

[45]  Yan Zhang,et al.  Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[46]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[47]  Lei Xu,et al.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.

[48]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[49]  K. Conley,et al.  Shaking up glycolysis: Sustained, high lactate flux during aerobic rattling. , 2001, Proceedings of the National Academy of Sciences of the United States of America.